Small Pharma Inc. DMT.V Stock
Small Pharma Inc. Price Chart
Small Pharma Inc. DMT.V Financial and Trading Overview
| Small Pharma Inc. stock price | 0.15 CAD |
| Previous Close | 0.07 CAD |
| Open | 0.07 CAD |
| Bid | 0.07 CAD x N/A |
| Ask | 0.07 CAD x N/A |
| Day's Range | 0.07 - 0.07 CAD |
| 52 Week Range | 0.06 - 0.4 CAD |
| Volume | 6K CAD |
| Avg. Volume | 106.34K CAD |
| Market Cap | 20.9M CAD |
| Beta (5Y Monthly) | 1.818069 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | 0 CAD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 3.75 CAD |
DMT.V Valuation Measures
| Enterprise Value | -1842726 CAD |
| Trailing P/E | N/A |
| Forward P/E | -1.0833334 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 1.1016948 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | 0.076 |
Trading Information
Small Pharma Inc. Stock Price History
| Beta (5Y Monthly) | 1.818069 |
| 52-Week Change | -43.47% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 0.4 CAD |
| 52 Week Low | 0.06 CAD |
| 50-Day Moving Average | 0.07 CAD |
| 200-Day Moving Average | 0.11 CAD |
DMT.V Share Statistics
| Avg. Volume (3 month) | 106.34K CAD |
| Avg. Daily Volume (10-Days) | 87.79K CAD |
| Shares Outstanding | 321.56M |
| Float | 227.93M |
| Short Ratio | 0.23 |
| % Held by Insiders | 31.08% |
| % Held by Institutions | 3.05% |
| Shares Short | 29.59K |
| Short % of Float | N/A |
| Short % of Shares Outstanding | 0.010% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | February 28, 2022 |
| Most Recent Quarter (mrq) | November 30, 2022 |
| Next Fiscal Year End | February 28, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -41.24% |
| Return on Equity (ttm) | -78.25% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -24275440 CAD |
| Net Income Avi to Common (ttm) | -25253232 CAD |
| Diluted EPS (ttm) | -0.07 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 22.74M CAD |
| Total Cash Per Share (mrq) | 0.07 CAD |
| Total Debt (mrq) | 0 CAD |
| Total Debt/Equity (mrq) | N/A |
| Current Ratio (mrq) | 4.106 |
| Book Value Per Share (mrq) | 0.059 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -22778842 CAD |
| Levered Free Cash Flow (ttm) | -12778564 CAD |
Profile of Small Pharma Inc.
| Country | Canada |
| State | N/A |
| City | London |
| Address | 6-8 Bonhill Street |
| ZIP | EC2A 4BX |
| Phone | N/A |
| Website | https://www.smallpharma.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | N/A |
Small Pharma Inc., a biotechnology company, focuses on developing short-acting psychedelics with therapy for the treatment of mental health conditions. Its clinical program is N,N-dimethyltryptamine assisted therapy to treat major depressive disorder. The company's product includes SPL026 Placebo, which is in clinical Phase IIA for the treatment of major depressive disorder. Its preclinical stage programs include SPL028, a prolonged DMT series; SPL029, an oral DMT series; and SPL801 oral formulation of 6-hydroxynorketamin. The company was incorporated in 2015 and is headquartered in London, the United Kingdom.
Q&A For Small Pharma Inc. Stock
What is a current DMT.V stock price?
Small Pharma Inc. DMT.V stock price today per share is 0.15 CAD.
How to purchase Small Pharma Inc. stock?
You can buy DMT.V shares on the TSXV exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Small Pharma Inc.?
The stock symbol or ticker of Small Pharma Inc. is DMT.V.
Which industry does the Small Pharma Inc. company belong to?
The Small Pharma Inc. industry is Biotechnology.
How many shares does Small Pharma Inc. have in circulation?
The max supply of Small Pharma Inc. shares is 335.77M.
What is Small Pharma Inc. Price to Earnings Ratio (PE Ratio)?
Small Pharma Inc. PE Ratio is 0.00000000 now.
What was Small Pharma Inc. earnings per share over the trailing 12 months (TTM)?
Small Pharma Inc. EPS is 0 CAD over the trailing 12 months.
Which sector does the Small Pharma Inc. company belong to?
The Small Pharma Inc. sector is Healthcare.